Evidence map›Paper›PMID 42725054›Full record

ArticleFrontiers in immunology2026

Case Report: Post-mortem analysis of long-term inflammation after mild COVID-19.

Yang Wu, Yu Kit Chan, Denise Goh, Belinda Lee, Felicia Wee, Mai Chan Lau, Paul Chui, Thuan Tong Tan, Jabed Iqbal, Akhila Balachander and 4 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yang Wu *Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Yu Kit Chan *National Centre for Infectious Diseases, Singapore, Singapore.
Denise Goh *Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Belinda Lee *Forensic Medicine Division, Health Sciences Authority, Singapore, Singapore.
Felicia WeeInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Mai Chan LauBioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Paul ChuiForensic Medicine Division, Health Sciences Authority, Singapore, Singapore.
Thuan Tong TanDepartment of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
Jabed IqbalDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Akhila BalachanderSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Craig Ryan JosephIntegrated Central Operations and Research Enablers (ICORE), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Lisa F P NgInfectious Diseases Labs (ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Yee Sin LeoNational Centre for Infectious Diseases, Singapore, Singapore.
Joe YeongThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent inflammation and tissue injury may contribute to post-acute COVID-19 syndrome (PACS). However, direct tissue evidence from mildly-infected individuals sampled long after recovery remains exceptionally limited. Here, we performed post-mortem bulk RNA-seq and GeoMx digital spatial profiling of lung, heart, and brain tissues from four individuals who recovered from mild COVID-19 more than 250 days before death from unrelated causes. Samples were collected during the early phase of the national vaccination program, before widespread vaccine uptake and recurrent infection, providing a rare reference cohort for defining tissue responses to SARS-CoV-2 in the absence of major confounding from vaccination and/or reinfection; such a cohort can no longer be prospectively assembled. We observed residual SARS-CoV-2 nucleocapsid antigen within tissues and revealed organ-specific immune alterations. Lung and heart tissues exhibited a coordinated, self-sustaining inflammatory response, whereas brain tissue showed vascular dysfunction and altered neuroimmune homeostasis. These findings showcase the distinct tissue responses following mild infection and provide a spatially resolved view of sub-clinical long-term tissue sequelae. Collectively, our data establish a unique baseline for persistent viral antigen and tissue-specific immune dysregulation underlying PACS.

Indexed as

COVID-19InflammationAdultAutopsyBrainHumansLungMaleMiddle AgedMyocardiumSpatial Transcriptomicsimmune dysregulationmacrophagepost-acute COVID-19 syndrome (PACS)post-mortem cohortSARS-CoV-2spatial transcriptomicstissue inflammationviral persistence

Identifiers

PMID42725054
PMCPMC13559925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.